Shemia Fagan, Oregon Secretary of State @OregonSOS
That 2018 report identified the ways in which state law constrained the effectiveness of the Oregon Prescription Drug Monitoring Program, such as by limiting the type of data that could be collected, ways in which it could be analyzed, and entities with whom it could be shared. — PolitiTweet.org